Markus Loeffler OR Markus Löffler
Markus Loeffler OR Markus Löffler
Institute for Medical Informatics, Statistics and Epidemiology
Verified email at - Homepage
Cited by
Cited by
Intensive insulin therapy and pentastarch resuscitation in severe sepsis
FM Brunkhorst, C Engel, F Bloos, A Meier-Hellmann, M Ragaller, N Weiler, ...
New England Journal of Medicine 358 (2), 125-139, 2008
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by …
M Pfreundschuh, L Trümper, A Österborg, R Pettengell, M Trneny, K Imrie, ...
The lancet oncology 7 (5), 379-391, 2006
Stem cells: attributes, cycles, spirals, pitfalls and uncertainties lessons for and from the crypt
CS Potten, M Loeffler
Development 110 (4), 1001-1020, 1990
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
B Chapuy, C Stewart, AJ Dunford, J Kim, A Kamburov, RA Redd, ...
Nature medicine 24 (5), 679-690, 2018
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)
M Pfreundschuh, J Schubert, M Ziepert, R Schmits, M Mohren, ...
The lancet oncology 9 (2), 105-116, 2008
A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling
M Hummel, S Bentink, H Berger, W Klapper, S Wessendorf, TFE Barth, ...
New England Journal of Medicine 354 (23), 2419-2430, 2006
Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease
V Diehl, J Franklin, M Pfreundschuh, B Lathan, U Paulus, D Hasenclever, ...
New England Journal of Medicine 348 (24), 2386-2395, 2003
Epidemiology of sepsis in Germany: results from a national prospective multicenter study
C Engel, FM Brunkhorst, HG Bone, R Brunkhorst, H Gerlach, S Grond, ...
Intensive care medicine 33, 606-618, 2007
Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the …
C Hartmann, B Hentschel, W Wick, D Capper, J Felsberg, M Simon, ...
Acta neuropathologica 120, 707-718, 2010
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL
M Pfreundschuh, L Trümper, M Kloess, R Schmits, AC Feller, C Rübe, ...
Blood 104 (3), 634-641, 2004
Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial
F Edelmann, R Wachter, AG Schmidt, E Kraigher-Krainer, C Colantonio, ...
Jama 309 (8), 781-791, 2013
CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the …
M Pfreundschuh, E Kuhnt, L Trümper, A Österborg, M Trneny, L Shepherd, ...
The lancet oncology 12 (11), 1013-1022, 2011
Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: results of the Ex-DHF (Exercise training in …
F Edelmann, G Gelbrich, HD Düngen, S Fröhling, R Wachter, ...
Journal of the American College of Cardiology 58 (17), 1780-1791, 2011
Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network
M Weller, J Felsberg, C Hartmann, H Berger, JP Steinbach, J Schramm, ...
Journal of Clinical Oncology 27 (34), 5743-5750, 2009
Standard International Prognostic Index Remains a Valid Predictor of Outcome for Patients With Aggressive CD20+ B-Cell Lymphoma in the Rituximab Era
M Ziepert, D Hasenclever, E Kuhnt, B Glass, N Schmitz, M Pfreundschuh, ...
Journal of clinical oncology 28 (14), 2373-2380, 2010
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
A Xue, Y Wu, Z Zhu, F Zhang, KE Kemper, Z Zheng, L Yengo, ...
Nature communications 9 (1), 2941, 2018
Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake
M Loeffler, JA Krüger, AG Niethammer, RA Reisfeld
The Journal of clinical investigation 116 (7), 1955-1962, 2006
Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma …
N Schmitz, L Trümper, M Ziepert, M Nickelsen, AD Ho, B Metzner, N Peter, ...
Blood, The Journal of the American Society of Hematology 116 (18), 3418-3425, 2010
Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study
A Engert, V Diehl, J Franklin, A Lohri, B Dörken, WD Ludwig, P Koch, ...
Journal of Clinical Oncology 27 (27), 4548-4554, 2009
MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma
H Horn, M Ziepert, C Becher, TFE Barth, HW Bernd, AC Feller, W Klapper, ...
Blood, The Journal of the American Society of Hematology 121 (12), 2253-2263, 2013
The system can't perform the operation now. Try again later.
Articles 1–20